Pharmaceutical Technology

JULY 25, 2022

The COVID-19 pandemic triggered significant changes to the way healthcare operates. Digitalization is now in full swing as medical care integrates with ICT to take the patient experience to the next level. These healthcare providers will offer telemedicine, allowing remote patient monitoring from the comfort of the patients’ own homes.

Pharmaceutical 114

Pharmaceutical Engineering Healthcare Provider Healthcare 114

World of DTC Marketing

MARCH 23, 2021

The media, rather than focus on the real driver of high healthcare costs, loves to point the finger at big pharma. percent of total health-care spending—in 2016, the last year for which there are definitive data. The drug industry has had a large target on its back for a long time. The post Drug price negotiations on the horizon.

Distribution 187

Distribution Prescription FDA Pharma 187

Pharma Marketing Network

MARCH 23, 2023

One of the biggest opportunities presented by big data in the pharmaceutical industry is the ability to gain insights into patient needs and preferences. One of the biggest challenges is ensuring that patient privacy is protected. 1 (2016) 3. 8 (2018) 2. Hardoon and Susan E.

Pharmaceutical 52

Pharmaceutical Marketing Electronics Media 52

Clarivate

MAY 24, 2022

Recent policy and regulatory moves have begun to sketch out a framework for rare disease drug approvals in the country, but obstacles to approvals and patient access remain. Mainland China has taken significant steps toward improving access to treatment for its estimated 20 million rare disease patients in recent years. [1]

Patients 52

Patients Food and Drug Administration Marketing Pharma 52

PM360

JUNE 26, 2023

For example, the Access Accelerated initiative was launched by 22 pharmaceutical companies in 2016 to help improve access to non-communicable disease medicines in emerging markets. These partnerships can be with local governments, healthcare providers, local startups, and non-governmental organizations.

Medicine 98

Medicine Marketing Pharma Manufacturing 98

European Pharmaceutical Review

OCTOBER 27, 2023

Benefits of The Future Clinical Trials Bill Chiefly, the Bill’s goal is to increase patient participation and overall, ensure clinical trials have the highest levels of safety while enabling greater regulatory pragmatism, the author explained. This is according to a 2016 paper published in Clinical and Translational Oncology.

Ethics 87

Ethics Medicine Education Competition 87

Pharmaceutical Technology

MARCH 24, 2023

However, it has taken over six years for Amjevita to launch, after first being FDA-approved in 2016. Many other biosimilars have also been FDA-approved since 2016. Further, there remains scepticism on the efficacy and safety of biosimilars. Sometimes the settlement of a patent dispute involves agreeing to defer entry.

Competition 59

Competition Marketing FDA Physicians 59

pharmaphorum

AUGUST 11, 2022

In 2016, the estimated annual cost of drug-related morbidity and mortality resulting from non-optimised medication therapy was $528.4 There have been great strides made in genomics to refine tools that determine the safest, most effective course of treatments for patients across a number of disease states.

Side effects 94

Side effects Medical Prescription Patients 94

PM360

MAY 15, 2023

The companies will also use generative AI to design mRNA medicines with optimal “safety and performance.” Both companies hope that the partnership will enable them to make significant advancements in drug discovery and ultimately improve patient outcomes.

Safety 52

Safety Healthcare Healthcare Electronics 52

World of DTC Marketing

DECEMBER 10, 2020

SUMMARY: (JAMA) The median drug wholesale list price (as defined by Average Wholesale Price) increased by 129% from 2010-2016, while median patient out-of-pocket costs increased by 53% and median insurance payments after rebates and discounts increased by 64%. Say goodbye to all the supposed goodwill.

Insurance 181

Insurance Pharma Manufacturing Retail 181

European Pharmaceutical Review

SEPTEMBER 22, 2023

Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Treatment with the mAbs delayed cognitive decline by 2.6 months for lecanemab and 5.5

Food and Drug Administration 78

Food and Drug Administration Safety Patients Leads 78

pharmaphorum

JANUARY 4, 2023

The intention is to streamline the process for patients wishing to access their medical records via electronic health record systems (“EHR systems”) and to facilitate the ability for researchers, innovators, and policy makers to use the data in a trusted and secure way that preserves privacy. General Data Protection Regulation 2016/679.

Pharmaceutical 95

Pharmaceutical Electronics Healthcare Healthcare 95

Clarify Health

MARCH 1, 2023

1] In a separate, controlled study, 80 percent of primary care physicians receiving micro-incentives referred patients to higher-value specialists they had never used before — representing a significant reduction in the total cost of care. Healthcare (2016), [link] [2] Parikh, R. million on orthopedic MS-DRGs.[1]

Physicians 52

Physicians Prescription Medicine Healthcare 52

Clarify Health

DECEMBER 13, 2022

Less than four percent of Americans participate in clinical studies; 30 percent of patients drop out; and 80 percent of studies do not meet enrollment deadlines. Dr. Rizk provided an example of how we’re getting better at meeting patients where they are. Life sciences and healthcare are becoming united.

Recruitment 52

Recruitment Retail Patients Education 52

European Pharmaceutical Review

FEBRUARY 22, 2023

Of the 175 new drugs approved by the US Food and Drug Administration (FDA) between 2016 and 2019, most were biologics. Of the 175 new drugs approved by the US Food and Drug Administration (FDA) between 2016 and 2019, most were biologics. We can see a future where millions of patients no longer carry the burden of regular injections.”

Food and Drug Administration 89

Food and Drug Administration Manufacturing Safety Pharmaceutical 89

Clarify Health

DECEMBER 13, 2022

Less than four percent of Americans participate in clinical studies; 30 percent of patients drop out; and 80 percent of studies do not meet enrollment deadlines. Dr. Rizk provided an example of how we’re getting better at meeting patients where they are. Life sciences and healthcare are becoming united.

Recruitment 52

Recruitment Retail Patients Education 52

Clarivate

SEPTEMBER 1, 2022

While some high-profile issues related to women’s rights and safety make the news cycle, gender inequalities are firmly entrenched in every society, impacting the daily lives of women and girls in ways that are rarely reported on. This knowledge is shaping research and clinical practice.”.

Education 124

Education Healthcare Healthcare Prospecting 124

European Pharmaceutical Review

DECEMBER 19, 2023

A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient. About 800 million humans are injected with vaccines every year” Most vaccines in use today are relatively cheap to make and are injected into patients with mass‑produced and inexpensive (five-cent) disposable syringes.

Distribution 100

Distribution Manufacturing Food Specialization 100